Vaccine-preventable disease hospitalized patients with heart failure with reduced ejection fraction.

ABSTRACT:

Background

Over five million Americans suffer from heart failure (HF), and this is associated with multiple chronic comorbidities and recurrent decompensation. Currently, there is an increased incidence in vaccine-preventable diseases (VPDs). We aim to investigate the impact of HF with reduced ejection fraction (HFrEF) in patients hospitalized with VPDs.

Hypothesis

Patient with HFrEF are at higher risk for VPDs and they carry a higher risk for in-hospital complications.

Methods

Retrospective analysis from all hospital admissions from the 2016-2018 National Inpatient Sample (NIS) using the ICD-10CM codes for patients admitted with a primary diagnosis of VPDs with HFrEF and those without reduced ejection fraction. Outcomes evaluated were in-hospital mortality, length of

SUBMITTER: Del Cid Fratti J 

PROVIDER: S-EPMC9045068 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature